Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Kelie H. Luby

I first heard about Mint Medical in 2013 when a colleague said: ‘you have to see this software - this will change everything.’ At this time, I was part of the imaging Contract Research Organizations (iCROs) ecosystem, working in the area of imaging centrally read clinical trials, primarily in oncology. What my colleague and I realized was that mint Lesion™ allows you to ask for more.

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

RANZCR Brisbane 2023

10/19 to 10/21/2023 BRISBANE, AUSTRALIA

73rd Annual Scientific Meeting

A picture of a person looking at a brain scan and the interface of mint Lesion™ on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…